Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
about
Endocrine FGFs: Evolution, Physiology, Pathophysiology, and PharmacotherapyPotential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany StudyFibroblast growth factor 23 and risk of incident stroke in community-living adultsEpidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.Serum phosphorus levels and risk of incident dementia.Evidence to Maintain the Systolic Blood Pressure Treatment Threshold at 140 mm Hg for Stroke Prevention: The Northern Manhattan StudyFibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of IndustrializationThe relationship of fibroblast growth factors 21 and 23 and α-Klotho with platelet activity measured by platelet volume indices.Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.αKlotho and Chronic Kidney Disease.Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.Paracrine Effects of FGF23 on the Heart.Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes
P2860
Q26781556-42EE9F34-6044-404A-BF85-2AC79AB2F915Q30316351-C1E80965-168C-4044-87EE-C4A75E0C96C3Q35019943-7A57D92F-98E3-420C-BA61-57EB3C1F1FD2Q35997370-3A01C7B5-49AC-4DD1-A3A9-CE56EFE8110FQ36004493-1AEB2D66-2FB3-480B-8347-F726D02C4F09Q36267683-8C05709A-E2E1-486F-ADC4-6F987405A29CQ36576594-7875BEDA-EFC4-4BAD-BD92-0C9979BEEE04Q36739628-6B748757-D6F7-4EED-9118-278E16A5D323Q36911491-84C9951C-90F9-4FF0-BC7E-CF90A9A901B1Q39028213-9DA20990-375D-41A1-9752-BCFDE3FEC51FQ39512523-4B67D7A7-2630-4879-A034-779D8D9CFB5BQ39812781-85BC1DD9-15BC-485F-89FA-F7CA1E010FC6Q40429347-FDADE848-1D0A-4BC2-A84C-804DE31F1F13Q41460824-914C40BB-6F4F-4BE6-A39B-B965CB6E9E6BQ51027820-18E2AE48-0B1A-4C36-A639-A072BA9F2A85Q55221465-33FFBA47-D349-4C0C-A51A-E3FCE9A270F9Q58760089-5CA47838-BE8A-4496-ADF5-1A1D75ABE455
P2860
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@ast
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@en
type
label
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@ast
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@en
prefLabel
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@ast
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@en
P2093
P2860
P1433
P1476
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
@en
P2093
Armando Mendez
Chuanhui Dong
Clinton B Wright
Matthew Stark
Mitchell S V Elkind
Myles Wolf
Shonni Silverberg
P2860
P304
P356
10.1212/WNL.0000000000000410
P407
P577
2014-04-04T00:00:00Z